Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin

J Natl Cancer Inst. 1997 Jun 4;89(11):817-8. doi: 10.1093/jnci/89.11.817.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antiemetics / therapeutic use*
  • Antineoplastic Agents / adverse effects*
  • Cisplatin / adverse effects*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurokinin-1 Receptor Antagonists*
  • Piperidines / therapeutic use*
  • Vomiting / chemically induced*
  • Vomiting / prevention & control*

Substances

  • Antiemetics
  • Antineoplastic Agents
  • Neurokinin-1 Receptor Antagonists
  • Piperidines
  • Cisplatin
  • (2S,3S)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine